BIODESIX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.575 USD | +0.96% |
|
-0.32% | -14.40% |
| May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
| May. 08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Presentation Operator MessageOperator (Operator)Welcome to the Biodesix Q1 2024 Earnings Confe...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Biodesix, Inc. (Biodesix) is a diagnostic solutions and services company. The Company develops diagnostic tests addressing clinical questions by combining multi-omics through the power of artificial intelligence. Biodesix offers over five Medicare-covered tests for patients with lung diseases. The blood based Nodify Lung Nodule Risk Assessment testing strategy, consisting of the Nodify XL2 and the Nodify CDT tests, evaluates the risk of malignancy in incidental pulmonary nodules, enabling physicians to better triage patients to the appropriate course of action. The blood based IQLung strategy for lung cancer patients integrates the GeneStrat targeted ddPCR test, the GeneStrat NGS test and the VeriStrat test to support treatment decisions across all stages of lung cancer. Biodesix also leverages the advanced Diagnostic Cortex artificial intelligence (AI) platform, to collaborate with biotechnology and pharmaceutical companies to solve complex diagnostic challenges in lung disease.
Calendar
2024-05-21
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.575
USD
Average target price
3.25
USD
Spread / Average Target
+106.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.40% | 179M | |
| -17.05% | 8.55B | |
| +65.23% | 4.24B | |
| -1.63% | 2.53B | |
| -9.81% | 2.44B | |
| -41.76% | 2.35B | |
| -8.53% | 1.89B | |
| -19.29% | 1.55B | |
| -39.61% | 1.23B | |
| +9.68% | 1.13B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024
